These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31900502)

  • 21. Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review.
    Murphy AE; Minhas D; Clauw DJ; Lee YC
    Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2215-2222. PubMed ID: 36785994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
    Angeletti C; Guetti C; Piroli A; Angeletti PM; Paladini A; Ciccozzi A; Marinangeli F; Varrassi G
    Pain Pract; 2013 Nov; 13(8):657-62. PubMed ID: 23126475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibromyalgia with chronic rheumatic diseases in South Korea: a comparison of clinical and American College of Rheumatology criteria.
    Choi HJ; Han JY; Seo MR; Ryu HJ; Baek HJ
    Int J Rheum Dis; 2017 Dec; 20(12):1922-1926. PubMed ID: 25990794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difficult to treat psoriatic arthritis - how should we manage?
    Kumthekar A; Ashrafi M; Deodhar A
    Clin Rheumatol; 2023 Sep; 42(9):2251-2265. PubMed ID: 37097525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
    Favalli EG; Monti S; Ingegnoli F; Balduzzi S; Caporali R; Montecucco C
    Arthritis Rheumatol; 2020 Oct; 72(10):1600-1606. PubMed ID: 32506699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical application of etanercept in Chinese patients with rheumatic diseases.
    Chou CT
    Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of vaccination in rheumatic disease.
    Wong PKK; Hanrahan P
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):720-734. PubMed ID: 31427051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of rheumatoid arthritis, clinical aspects and socio-economic determinants in Pakistani patients: A systematic review and meta-analysis.
    Naqvi AA; Hassali MA; Aftab MT
    J Pak Med Assoc; 2019 Mar; 69(3):389-398. PubMed ID: 30890833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets in rheumatic diseases: friend or foe?
    Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
    Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review.
    Van Herwaarden N; Van Den Bemt BJF; Wientjes MHM; Kramers C; Den Broeder AA
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):843-857. PubMed ID: 28686523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis.
    Duffield SJ; Miller N; Zhao S; Goodson NJ
    Rheumatology (Oxford); 2018 Aug; 57(8):1453-1460. PubMed ID: 29788461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
    Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.
    Bjornsson AH; Grondal G; Kristjansson M; Jonsdottir T; Love TJ; Gudbjornsson B;
    Ann Rheum Dis; 2021 May; 80(5):671-672. PubMed ID: 33402343
    [No Abstract]   [Full Text] [Related]  

  • 34. Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions.
    Cruz-Jentoft AJ; Romero-Yuste S; Chamizo Carmona E; Nolla JM
    Aging Clin Exp Res; 2021 Nov; 33(11):2929-2939. PubMed ID: 33566325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complexities of fibromyalgia and its comorbidities.
    Lichtenstein A; Tiosano S; Amital H
    Curr Opin Rheumatol; 2018 Jan; 30(1):94-100. PubMed ID: 29040155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    J Arthroplasty; 2022 Sep; 37(9):1676-1683. PubMed ID: 35732511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gililland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Rheumatol; 2022 Sep; 74(9):1464-1473. PubMed ID: 35722708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1399-1408. PubMed ID: 35718887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antirheumatic drugs in older adults and polypharmacy issues.
    Coskun Benlidayi I; Gokce Kutsal Y
    Z Gerontol Geriatr; 2022 Oct; 55(6):507-512. PubMed ID: 34114088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.